Webinar

2025 Outlook and Expectations for Global Pharma, Biotech

BI's global healthcare team will discuss issues, expectations and key events anticipated in 2024 for Pharma and Biotech. Topics include regulatory change, capital allocation, growth and valuation, disease area trends and anticipated catalysts.

Speakers

John Murphy

Senior Research Analyst

Bloomberg Intelligence

John Murphy is a senior equity analyst at Bloomberg Intelligence focused on large-cap Pharma. Prior to joining Bloomberg in 2021 John was a partner at Arkle Associates, an independent healthcare advisory company, and before that spent the majority of his career in healthcare equity research at Goldman Sachs. Additional experience includes working in drug discovery in the pharmaceutical industry. He gained a D.Phil in Biochemistry at the University of York and a BSc.(Hons) in Applied Biology from the University of Hertfordshire.

Duane Wright

Senior Research Analyst

Bloomberg Intelligence

Duane Wright is a Senior Analyst for the health team at Bloomberg Intelligence. Prior to joining Bloomberg he was a Vice President in the Government Affairs department for the Advanced Medical Technology Association (AdvaMed) where he was team lead on diagnostics, coverage and reimbursement issues, and led industry efforts to repeal the medical device tax in 2019. Prior to AdvaMed he was a Vice President at Finsbury Glover Hering, a multi-client consultant firm, and America’s Health Insurance Plans. Prior to his private sector work he was lead health staff for Senator Tom Carper (D-DE), and a Legislative Assistant to former Congressman Jim Davis (D-FL). Wright holds a law degree from The George Washington University, and a bachelor’s degree from the University of North Carolina at Chapel Hill.

Register

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Access a broad range of analysis, research, insight and actionable ideas with Bloomberg webinars.